Study of P53 Gene Mutations as a New Early Diagnostic Markers of Hepatocellular Carcinoma in Egyptian Patients

Madridge Journal of Oncogenesis
doi 10.18689/mjo-1000104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Madridge Publishers, LLC

Related search

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2015English

Diagnostic Value of Riz1 Gene Expression as a Potential Marker for Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2016English

P53 and Endoglin, Two Biomarkers for Predicting HBV and Hepatocellular Carcinoma in Egyptian Patients

Journal of advanced Biomedical and Pharmaceutical Sciences
2020English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Serum Exosomal microRNAs Combined With Alpha-Fetoprotein as Diagnostic Markers of Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Epidemiological and Clinical Characteristics of Egyptian Patients With Hepatocellular Carcinoma: A Single Center Study

International Journal of Medical and Health Sciences Research
2015English

Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Gastroenterology
HepatologyGastroenterology
2008English

BANF1, PLOD3, SF3B4 as Early-Stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

Investigating the Breath Metabolome as a Diagnostic Tool for Hepatocellular Carcinoma in Cirrhotic Patients

HPB
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy